Research
Metabolic adaptation
Retatrutide shows additional benefits for metabolic comorbidities such as NASH and cardiovascular disease.
Retatrutide may help manage obesity-related metabolic conditions.
StrongSupportsmedium confidence
with additional benefits for metabolic comorbidities such as NASH and cardiovascular disease.
Why this rating
Based on the mention of Phase 2 trials.
Source
The Triple‐Agonist Revolution: Retatrutide and the Paradigm Shift in Multi‐Hormonal Pharmacotherapy for Obesity and Cardiometabolic Comorbidities
Nila Ganamurali et al. · Clinical Pharmacology in Drug Development · 2026
DOI 10.1002/cpdd.70001
otherCited 2×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Metabolic adaptation
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →